Topic: Biologics

Using biologics in atopic dermatitis therapy

Jacqueline Louie | November 9, 2018 / News

Addressing drug plan sustainability in the face of rising costs

Jacqueline Louie | November 9, 2018 / News

Future trends in drug plan costs and the national pharmacare debate

Jacqueline Louie | November 9, 2018 / News

Successful management of speciality drugs requires a multi-pronged approach

Helen Burnett-Nichols | November 2, 2018 / News

Conference coverage: 2018 Halifax Benefits Summit

Staff | October 5, 2018 / News

Biosimilars have potential to offer relief for rising drug plan costs

donalee Moulton | October 5, 2018 / News

Personalizing biologic treatment in the age of biosimilars

donalee Moulton | October 5, 2018 / News

How NAFTA negotiations could affect drug prices, pharmacare

Staff | September 12, 2018 / Other

High-cost drugs account for 26% of private plan costs in 2017: PMPRB

Staff | August 24, 2018 / News

How one patient thrives despite four decades with rheumatoid arthritis

Michael McKiernan | July 4, 2018 / News